Title
Corporate Governance: Agency Problem, and Regulation in Nigeria Banking Industry: A case study of Oceanic bank Plc and Union ban,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 3–5 business days
- Estimated Delivery: 6–10 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
The author critically examined why corporate governance (CG)practices in Nigeria banks failed to solve agency problem despite additional guideline issued by the apex bank (Central bank of Nigeria). Two of the banks affected by recent banking reform in the country were used as the case study. The study answered the following questions; What is corporate governance and its functions in Nigerian banking industry? What are the common agency problems that manifest themselves in the principal agent relationship in the Nigeria banking industry? What is the role of Central bank regulation in ensuring sound corporate governance practices in Nigerian banks and why did it fail to unearth the agency problems? Holistic approach was used through diverse approaches in identifying and analyzing previous work on agency theory as it affects corporate governance. Some of Corporate governance dimensions examined in relation to principalagents relationships are board of director, ownership, integrity of financial reporting, transparency. Inconclusive examination determining CG effect on principalagent relationship necessitated the study.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.